Taiflex Scientific revenue and financials
$304.50Change from previous close: +3.05%Absolute change: +$9.00
In the fiscal year ended December 2025, Taiflex Scientific reported revenue of $10.61B (+6.75% year over year). Net income was $535.12M, a net margin of 5.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +6.75%
- 2025 vs 2024
- Net income growth
- −9.73%
- 2025 vs 2024
- Net margin
- 5.0%
- 2024: 6.0%
Financial data
Amounts in millions of TWD; per-share values in TWD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | 363 | 490 | 982 | — | 151 | -77.2 |
| Depreciation and amortization | 149 | 148 | 141 | — | 134 | 136 |
| Capital expenditure | -118 | -156 | -256 | — | -180 | -129 |
| Investing cash flow | 233 | -366 | -137 | — | 109 | -209 |
| Financing cash flow | -81.8 | 351 | 88.7 | — | 46.2 | 7.4 |
| Dividends paid | — | — | 0.0 | — | — | — |
| Debt issued | -72.0 | 338 | 33.6 | — | 55.5 | 6.0 |
| Debt repaid | 0.0 | 0.0 | -4.9 | — | -4.9 | -4.9 |
| Effect of exchange rates | 25.6 | 48.2 | 90.8 | — | -204 | 40.3 |
| Net change in cash | 514 | 475 | 934 | — | 306 | -279 |
| Free cash flow | 246 | 334 | 726 | — | -29.2 | -206 |